iTeos Therapeutics, Inc. (ITOS) Financials
ITOS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 667.6 million | 92.4 million |
2023-09-30 | 677.6 million | 79.4 million |
2023-06-30 | 703.7 million | 80.2 million |
2023-03-31 | 728.3 million | 76.1 million |
ITOS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -15.2 million | 7.2 million |
2023-09-30 | -34.6 million | 7.1 million |
2023-06-30 | -30.2 million | 7.0 million |
2023-03-31 | -26.7 million | 5.8 million |
ITOS Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -30.6 million |
2023-09-30 | -32.2 million |
2023-06-30 | -34.3 million |
2023-03-31 | -15.6 million |
ITOS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 531.9 million | - | 6.1 million |
2023-09-30 | 599.0 million | - | 5.9 million |
2023-06-30 | 599.2 million | - | 5.4 million |
2023-03-31 | 602.1 million | - | 4.6 million |
ITOS Shares Outstanding
ITOS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.4 million | 27.8 million | 12.4 million | - |
2023-09-30 | 751000 | 30.6 million | 12.6 million | - |
2023-06-30 | 700000 | 29.2 million | 13.4 million | - |
2023-03-31 | 119000 | 25.6 million | 11.9 million | - |
ITOS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 233000 |
2023-09-30 | - | 224000 |
2023-06-30 | - | 198000 |
2023-03-31 | 12.6 million | 224000 |
ITOS
Price: $11.66
52 week price:
Earnings Per Share: -3.15 USD
P/E Ratio: -5.75
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 231111
Market Capitalization: 397.9 million